Trading Day Triumph: Sana Biotechnology Inc (SANA) Ends at $3.29, a 1.86 Surge/Plunge

Nora Barnes

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

Sana Biotechnology Inc (NASDAQ: SANA) closed the day trading at $3.29 up 1.86% from the previous closing price of $3.23. In other words, the price has increased by $1.86 from its previous closing price. On the day, 2.98 million shares were traded. SANA stock price reached its highest trading level at $3.3779 during the session, while it also had its lowest trading level at $3.16.

Ratios:

For a better understanding of SANA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.55 and its Current Ratio is at 4.55. In the meantime, Its Debt-to-Equity ratio is 0.42 whereas as Long-Term Debt/Eq ratio is at 0.35.

Upgrades & Downgrades

In the most recent recommendation for this company, Wedbush on September 24, 2025, initiated with a Outperform rating and assigned the stock a target price of $5.

Citizens JMP Upgraded its Mkt Perform to Mkt Outperform on March 18, 2025, while the target price for the stock was maintained at $5.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 18 ’25 when CHRISTIAN HORDO & KATHARINE HO bought 75,000 shares for $3.16 per share.

CHRISTIAN HORDO & KATHARINE HO bought 75,000 shares of SANA for $289,500 on Jan 16 ’25. On Jan 08 ’25, another insider, FMR LLC, who serves as The insider 1 of the company, sold 290,912 shares for $6.49 each. As a result, the insider received 1,887,320 and left with 4,541,511 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SANA now has a Market Capitalization of 876344512 and an Enterprise Value of 813026560.

Stock Price History:

The Beta on a monthly basis for SANA is 2.07, which has changed by 0.32661295 over the last 52 weeks, in comparison to a change of 0.1028198 over the same period for the S&P500. Over the past 52 weeks, SANA has reached a high of $7.30, while it has fallen to a 52-week low of $1.26. The 50-Day Moving Average of the stock is -21.61%, while the 200-Day Moving Average is calculated to be 5.72%.

Shares Statistics:

Over the past 3-months, SANA traded about 4.79M shares per day on average, while over the past 10 days, SANA traded about 3549680 shares per day. A total of 262.26M shares are outstanding, with a floating share count of 165.89M. Insiders hold about 37.72% of the company’s shares, while institutions hold 49.04% stake in the company. Shares short for SANA as of 1761868800 were 31993395 with a Short Ratio of 6.68, compared to 1759190400 on 33413195. Therefore, it implies a Short% of Shares Outstanding of 31993395 and a Short% of Float of 32.75.

Earnings Estimates

The performance of Sana Biotechnology Inc (SANA) in the stock market is under the watchful eye of 4.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.

Analysts are recommending an EPS of between -$0.71 and -$0.8 for the fiscal current year, implying an average EPS of -$0.75. EPS for the following year is -$0.57, with 4.0 analysts recommending between -$0.38 and -$0.64.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.